Rena Mizrahi

Rena Mizrahi is an accomplished biotechnology professional currently serving as Vice President of Recombinant CMC Development at Grifols since February 2025, after Grifols' acquisition of GigaGen in 2021. With a rich background at GigaGen Inc from October 2014 to February 2025, Rena held various roles including Vice President of Process Development, Director of Protein Engineering, and Senior Scientist. Prior experience includes a postdoctoral position at Lawrence Berkeley National Laboratory focused on electron transport proteins, a graduate student role at the University of California, Davis, developing assays for RNA editing, and internships at Genentech and Maxygen involving protein purification and assay optimization. Rena holds a PhD in Chemistry with a Designated Emphasis in Biotechnology from the University of California, Davis, and a BA in Chemistry from Washington University in St. Louis.